Hormone replacement therapy increases isometric muscle strength of adductor pollicis in post-menopausal women
The DOI matches its Crossref record.
Abstract
A randomized open trial of hormone replacement therapy was used to assess changes in adductor pollicis muscle strength during 6–12 months of treatment with Prempak C 0.625® in comparison with an untreated control group. Muscle strength (maximal voluntary force; MVF), muscle cross-sectional area and bone mineral density were measured. Women entering the trial had oestrogen levels below 150 pmolċl-1, confirming their post-menopausal hormonal status. In the treated group, MVF increased by 12.4±1.0% (mean±S.E.M.) of initial MVF over the duration of treatment, while it declined slightly (2.9±0.9%) in the control group. This increase in strength could not be explained by an increase in muscle bulk, there being no significant increase in cross-sectional area during the study. Those subjects who were weakest at enrolment showed the greatest increases in muscle strength after treatment. Bone mineral density in total hip, Ward's triangle and total spine increased in the treated group, in agreement with previous studies. There was no correlation between the individual increases in bone mineral density and those in MVF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Muscle strength, power and adaptations to resistance training in older people
Macaluso, A., & De Vito, G. (2004) · European Journal of Applied Physiology · doi:10.1007/s00421-003-0991-3 · Cited by 554
The role of androgens and estrogens on healthy aging and longevity
Horstman, A. M., Dillon, E. L., Urban, R. J., & Sheffield-Moore, M. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls068 · Cited by 396
The Influence of Estrogen on Skeletal Muscle: Sex Matters
Enns, D. L., & Tiidus, P. M. (2010) · Sports Medicine · doi:10.2165/11319760-000000000-00000 · Cited by 374
SIPILÄ, S., TAAFFE, D. R., CHENG, S., PUOLAKKA, J., TOIVANEN, J., & SUOMINEN, H. (2001) · Clinical Science · doi:10.1042/cs1010147 · Cited by 230
Expression of Both Oestrogen Receptor Alpha and Beta in Human Skeletal Muscle Tissue
Wiik, A., Ekman, M., Johansson, O., Jansson, E., & Esbjörnsson, M. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0512-x · Cited by 190
“The eVects of oestrogen on skeletal muscle tissue have not been studied extensively, although a few reports indicate that it has a role in muscle strength development (Sarwar et al. 1996; Skelton et al. 1999 ).”
BackgroundElliott, K. J., Sale, C., & Cable, N. T. (2002) · British Journal of Sports Medicine · doi:10.1136/bjsm.36.5.340 · Cited by 180
Ronkainen, P. H. A., Kovanen, V., Alén, M., Pöllänen, E., Palonen, E.-M., Ankarberg-Lindgren, C., Hämäläinen, E., Turpeinen, U., Kujala, U. M., Puolakka, J., et al. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91518.2008 · Cited by 168
“In previous randomized controlled trials (RCTs), administration of postmenopausal hormone replacement therapy (HRT) for 6 mo to 1 yr has been documented to improve mobility and increase muscle strength among relatively young postmenopausal women (50, 53, 55), whereas among older women similar effects with treatment la…”
BackgroundInfluentialSchaap, L. A., Pluijm, S. M. F., Smit, J. H., Van Schoor, N. M., Visser, M., Gooren, L. J. G., & Lips, P. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02315.x · Cited by 168
Moran, A. L., Warren, G. L., & Lowe, D. A. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01029.2005 · Cited by 123
Oestrogen receptor β is expressed in adult human skeletal muscle both at the mRNA and protein level
Wiik, A., Glenmark, B., Ekman, M., Esbjörnsson‐Liljedahl, M., Johansson, O., Bodin, K., Enmark, E., & Jansson, E. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.0001-6772.2003.01186.x · Cited by 122
Difference in skeletal muscle function in males vs. females: role of estrogen receptor-β
Glenmark, B., Nilsson, M., Gao, H., Gustafsson, J.-Å., Dahlman-Wright, K., & Westerblad, H. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00098.2004 · Cited by 121
Effects of ovariectomy and estrogen on skeletal muscle function in growing rats
McCormick, K. M., Burns, K. L., Piccone, C. M., Gosselin, L. E., & Brazeau, G. A. (2004) · Journal of Muscle Research & Cell Motility · doi:10.1023/b:jure.0000021398.78327.39 · Cited by 102
Muscle performance, sex hormones and training in peri‐menopausal and post‐menopausal women
Sipilä, S., & Poutamo, J. (2003) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1034/j.1600-0838.2003.20210.x · Cited by 73
Aubertin-Leheudre, M., Lord, C., Khalil, A., & Dionne, I. J. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602695 · Cited by 70
Evaluation of the applicability of HRT as a preservative of muscle strength in women
Meeuwsen, I. B., Samson, M. M., & Verhaar, H. J. (2000) · Maturitas · doi:10.1016/s0378-5122(00)00132-8 · Cited by 57
Pöllänen, E., Ronkainen, P. H. A., Horttanainen, M., Takala, T., Puolakka, J., Suominen, H., Sipilä, S., & Kovanen, V. (2010) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2010.07.003 · Cited by 54
“Also other studies have documented that HRT increases muscle mass, improves body and muscle composition or promotes muscle function [18-23].”
BackgroundEffects of Ultra‐Low‐Dose Estrogen Therapy on Muscle and Physical Function in Older Women
Kenny, A. M., Kleppinger, A., Wang, Y., & Prestwood, K. M. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53567.x · Cited by 50
Knowles, O. E., Aisbett, B., Main, L. C., Drinkwater, E. J., Orellana, L., & Lamon, S. (2019) · Sports Medicine · doi:10.1007/s40279-019-01132-7 · Cited by 48
Metadata
- Authors
- SKELTON, D. A., PHILLIPS, S. K., BRUCE, S. A., NAYLOR, C. H., & WOLEDGE, R. C.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 1999-04-01
- Volume
- 96
- Issue
- 4
- Pages
- 357-364
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2075714200
- Cited by
- 154
- References
- 0
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.